DNP-modified autologous renal cell carcinoma tumor cell vaccine
Term · Oncology and biomedicine · MLC-T-ONC-013112
A cancer vaccine consisting of autologous renal cell carcinoma (RCC) tumor cells modified with the hapten 2,4-dinitrophenol (DNP) with potential immunostimulating and antineoplastic activities. Administration of DNP-modified autologous renal cell carcinoma tumor cell vaccine may induce a cytotoxic T-lymphocyte (CTL) response against renal cell carcinoma tumor cells. DNP conjugation may enhance the immunogenicity of weakly immunogenic antigens.
| Identifier | MLC-T-ONC-013112 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | dinitrophenyl-modified autologous renal cell carcinoma tumor cell vaccine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013112",
"term": "DNP-modified autologous renal cell carcinoma tumor cell vaccine",
"field": "Oncology and biomedicine",
"definition": "A cancer vaccine consisting of autologous renal cell carcinoma (RCC) tumor cells modified with the hapten 2,4-dinitrophenol (DNP) with potential immunostimulating and antineoplastic activities. Administration of DNP-modified autologous renal cell carcinoma tumor cell vaccine may induce a cytotoxic T-lymphocyte (CTL) response against renal cell carcinoma tumor cells. DNP conjugation may enhance the immunogenicity of weakly immunogenic antigens.",
"synonyms": [
"dinitrophenyl-modified autologous renal cell carcinoma tumor cell vaccine"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/dnp-modified-autologous-renal-cell-carcinoma-tumor-cell-vaccine/"
}
Record 6,134 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.